Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00600158 · ClinicalTrials.gov registry record · Phase 3

Effects of Intravenous Local Anesthetic on Bowel Function After Colectomy

A Phase 3 study of Postoperative Ileus, sponsored by University of Virginia.

Completed
Registry status
Phase 3
Development phase
45
Enrollment target
1
Study location

NCT00600158 is a Phase 3 study of Postoperative Ileus that has completed, run by University of Virginia. The registered enrollment target is 45 participants, below the 96-participant average among 3 other Postoperative Ileus trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00600158, a Phase 3 study of Postoperative Ileus, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
Phase 3
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

Epidural local anesthetics are the gold standard for shortening duration of bowel dysfunction after bowel surgery. Previous studies suggest that their effect may be in part a result of actions of the local anesthetic outside the epidural space. If local anesthetics could be administered intravenously instead, this might be a safer, easier and less expensive approach. Therefore, this trial will compare the effect on bowel function recovery of intravenous local anesthetics with those administered epidurally.

Conditions Studied

Interventions

  • DRUG lidocaine
  • DRUG bupivacaine with hydromorphone

Study Locations (1)

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2005-04
Est. Completion 2006-07
Phase Phase 3

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT00600158

The ClinicalTrials.gov registry entry for NCT00600158 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 96-participant average among 3 other Postoperative Ileus trials with a reported enrollment target (53% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postoperative Ileus appearing as the primary indexed condition, and to 2 interventions - of which lidocaine is the first listed.

NCT00600158 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT00600158 about?

NCT00600158 is a clinical study titled "Effects of Intravenous Local Anesthetic on Bowel Function After Colectomy". Epidural local anesthetics are the gold standard for shortening duration of bowel dysfunction after bowel surgery. Previous studies suggest that their effect may be in part a result of actions of the local anesthetic outside the epidural space. If local anesthetics could be administered intravenousl...

What is the current status of trial NCT00600158?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 45 participants. The study started on 2005-04. Estimated completion is 2006-07.

What conditions does trial NCT00600158 study?

This clinical trial studies the following conditions: Postoperative Ileus.

What interventions are being tested in trial NCT00600158?

The interventions under investigation include: lidocaine (DRUG), bupivacaine with hydromorphone (DRUG).

Who is sponsoring clinical trial NCT00600158?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00600158 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Ileus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.